Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 11,794

Document Document Title
WO/2007/032028A1
The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specificat...  
WO/2007/033002A1
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: (F) where the definitions of the variables Q, L1, , L2, M, X, L3, and A are provided ...  
WO/2007/030385A2
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO2006106437A8
The present invention relates to novel compounds selected from substituted oxazole derivatives of formula (I) that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinas...  
WO/2007/030386A2
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/030385A3
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/029036A3
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...  
WO/2007/030386A3
An improved method of preparing oxazolidine protected aminodiol compounds is disclosed. These compounds are useful intermediates in processes for making Florfenicol.  
WO/2007/029036A2
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or stereoisomers thereof. The compounds of the present invention are inhibitors of histone deacetylase (HDAC) and are useful for treating cel...  
WO/2007/025709A2
The invention relates to novel diamines of the formula (I) in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments ...  
WO/2007/026753A1
Disclosed is a method for producing a 2-oxazoline analogue or a 1,3-oxazine analogue represented by the general formula (3) below wherein 1,2-aminoalcohol or 1,2-aminothiol is reacted with α,α-dihaloamine. (3) (In the formula, n is 0 o...  
WO/2007/025709A3
The invention relates to novel diamines of the formula (I) in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments ...  
WO/2007/023141A1
The present invention relates to N-oxides of certain piperazine and piperidine derivatives and to methods for the preparation of these compounds. The invention also relates to the use of compounds disclosed herein for the manufacture of ...  
WO/2007/020936A1
It is intended to provide a 1,6-β-glucan synthase inhibitor which strongly inhibits proliferation and has a high safety. It is intended to provide a compound which can specifically or selectively expressing an antifungal action on a bro...  
WO/2007/017687A2
A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; L' is a single bond, -O- or -C(=O)-; A is selected from the group consisting...  
WO/2007/017414A1
Dicyanoalkane compounds of formula (I), wherein R1, R2, R3,R4 and A are defined as in the description, or the enantiomers or diastereomers or salts thereof are subject matter of the present invention. Further also processes and intermedi...  
WO/2007/017546A2
The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subs...  
WO/2007/019080A3
The present invention is directed to tricyclic compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The ...  
WO/2007/017669A1
Compounds of formula (I) are useful in the treatment of diseases where enhanced M3 receptor activation is implicated, such as respiritory tract diseases: wherein (i) R1 is C1-C6-alkyl or hydrogen; and R2 is hydrogen or a group -R7, -Z-Y-...  
WO/2007/017687A3
A compound of formula (III): or a salt, solvate and chemically protected form thereof, wherein: R5 is an optionally substituted C5-20 aryl or C4-20 alkyl group; L' is a single bond, -O- or -C(=O)-; A is selected from the group consisting...  
WO/2007/016979A2
The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, Formula (III) wherein R3 is H...  
WO2005123703A8
The present invention relates to novel compounds of formula (I) wherein W, n, X and W' are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 ("mGluR5") which are useful for the...  
WO/2007/017546A3
The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subs...  
WO/2007/016979A3
The present invention relates to compounds of the general formula (III) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof, Formula (III) wherein R3 is H...  
WO2006021420B1
The invention relates to a method for producing diarylcycloalkyl derivatives of general formula (I), wherein the radicals have the indicated meanings. The invention further relates to novel intermediate products that are formed by means ...  
WO/2007/015809A3
Compounds having the structure: are HIV reverse transcriptase inhibitors, wherein A, X, Y, Z, R1 and R2 are defined herein. The compounds and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcripta...  
WO2006069811B1
Compounds of Formula (4) or (5) that absorb ultraviolet light 380 nm to 400 nm range but avoid absorption in the blue light range, thereby imparting yellowness, i.e., 410-420 nm: have suitable refractive characteristics useful in the pre...  
WO/2007/015533A1
Disclosed is a novel amidine compound which can serve as an active ingredient of a highly safe herbicide which shows a reliable effect at a low dose. Also disclosed is a herbicide comprising the compound as an active ingredient. An amidi...  
WO/2007/013694A1
A compound represented by the general formula (I): (I) wherein each symbol is as defined in the description. The compound is excellent in the effect of decreasing the blood glucose level and the blood lipid level, and therefore is useful...  
WO/2007/014023A1
The present invention relates to certain single-enantiomer pyrrazol-4-yl derivatives of thiazolidinones, oxazolidinones, and pyrrolidinones which are useful in the treatment of Hepatitis B virus.  
WO/2007/014290A3
This invention is directed to compounds of Formula (1) including all geometric and stereoisomers, N oxides, and agriculturally suitable salts thereof, agricultural compositions containing them and their use as fungicides, (1) provided th...  
WO/2007/009389A3
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  
WO/2007/010653A1
A salt molten at room temperature that does not contain any organic solvent, excelling in stability; and a display device that is improved in the durability in high-temperature environment by virtue of the use thereof. There is provided ...  
WO/2007/009389A2
The present invention provides compounds of formula (I), the preparation thereof and their use as peroxisome proliferator activated receptor-γ (PPAR-γ) agonist in the treatment of diabetes and diabetic complications.  
WO2006110155B1
Novel crystalline forms of Linezolid, designated as Form TIII, Form V, Form VI, Form IX, Form X, Form XII, Form XIV, Form XVII, and Form XVIII, are disclosed. The novel crystalline forms are characterized by powder X-ray diffraction, FTI...  
WO/2007/005583A1
The present invention provides methods for preparing TLR-4 receptor agonist E6020 formula(I): and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bac...  
WO/2007/005531A3
Non-nucleoside inhibitors of HIV-I reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds des...  
WO/2007/005572A1
An efficient process is disclosed for producing a compound that is an inhibitor of CETP. The last step of the process is the coupling of an oxazolidinone derivative with a biphenyl moiety to provide a compound of formula (I). In a specif...  
WO/2007/003419A1
The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R3, R4, G, Y, W and...  
WO/2007/005531A2
Non-nucleoside inhibitors of HIV-I reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds des...  
WO/2007/004032A1
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt as antibacterial agents.  
WO/2007/005000A1
The invention relates to methods of synthesizing 2-substituted azole compunds of formula (I). The invention is also relates to compounds of formula (I) and to intermediate compounds in the synthesis method.  
WO/2007/002173A1
One aspect of the invention relates to the design, synthesis and biological activity of novel HIV-1 protease inhibitors incorporating N-phenyloxazolidine-5-carboxamides into the (hydroxyethylamino)sulfonamide scaffold as P2 ligands. For ...  
WO2005012297A9
Leukotriene A4 hydrolase (LTA4H) inhibitors of Formula (I), compositions containing them, and their use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and/or conditions associated ...  
WO/2007/000235A1
The invention relates to alkoxymethyl-substituted benzoic acid derivatives and to the physiologically compatible salts thereof and physiologically functional derivatives thereof. The invention also relates to compounds of formula (I), wh...  
WO2006091848A3
The present invention provides an isolated linezolid (1) impurity, bis-linezolid (4), preparation thereof and its use as a reference standard.  
WO2005087752A8
The invention relates to novel aminoalkanol derivatives and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disord...  
WO/2006/138660A3
The invention relates to substituted adamantane compounds of formula (I), pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferati...  
WO/2006/138328A1
The present invention provides a convergent process for the preparation of a family of antidiabetic phenoxy-substituted phenoxybenzyl oxazolidinediones shown as structure I. The compounds are selective PPAR gamma partial agonists (SPPARM...  
WO2005072376A3
One aspect of the present invention relates to ionic liquids comprising an anionic sweetener. Another aspect of the present invention relates to the use of an ionic liquid of the present invention comprising a pendant Bronsted-acidic gro...  

Matches 1,001 - 1,050 out of 11,794